AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3572208 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 400 mg
Number of subjects: 27
Study 3572208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31083158 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional balloon technique (group 2)
Number of subjects: 100
Study 31083158 — intervention group
Group type: COMPARATOR
Intervention: Traditional nondirectional balloon technique (group 1)
Number of subjects: 100
Study 28681698 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste (1450 ppm)
Number of subjects: 12
Study 28681698 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth Mousse™ in addition to fluoride toothpaste
Number of subjects: 12
Study 25957570 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-toxicant-prototype cigarette (RTP)
Number of subjects: 0
Study 25957570 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarette (control)
Number of subjects: 0
Study 25957570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RTP and control)
Number of subjects: 0
Study 22812702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation television ads
Number of subjects: 3411
Study 21778247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-field proton MR spectroscopy measuring NAA/mIns ratio in ALS patients
Number of subjects: 24
Study 21778247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-field proton MR spectroscopy measuring NAA in ALS patients
Number of subjects: 24
Study 21778247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-field proton MR spectroscopy measuring mIns in ALS patients
Number of subjects: 24
Study 21778247 — intervention group
Group type: COMPARATOR
Intervention: High-field proton MR spectroscopy measuring NAA/mIns ratio in healthy controls
Number of subjects: 24
Study 19433800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/day) and Vitamin E (400 IU/day)
Number of subjects: 39
Study 19433800 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise without antioxidants
Number of subjects: 39
Study 17105584 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g alcohol (group 1)
Number of subjects: 21
Study 17105584 — intervention group
Group type: COMPARATOR
Intervention: Non-alcoholic beverage (group 2)
Number of subjects: 21
Study 15336468 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/Acetaminophen 75/650 mg (Tr/Ac)
Number of subjects: 128
Study 15336468 — intervention group
Group type: COMPARATOR
Intervention: Codeine/Acetaminophen/Ibuprofen 20/500/400 mg (Co/Ac/Ib)
Number of subjects: 128
Study 11371683 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12-week supervised exercise program)
Number of subjects: 60
Study 11371683 — intervention group
Group type: COMPARATOR
Intervention: Control (usual activity)
Number of subjects: 60
Study 11371683 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 60
Study 9672864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter
Number of subjects: 1721
Study 9672864 — intervention group
Group type: COMPARATOR
Intervention: Control group (no catheter)
Number of subjects: 1721
Study 7862884 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (150 mg daily)
Number of subjects: 30
Study 7862884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7862884 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 30
Study 2502165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (15 mg 70 kg-1)
Number of subjects: 6
Study 2502165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (30 mg 70 kg-1)
Number of subjects: 6
Study 2502165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (60 mg 70 kg-1)
Number of subjects: 6
Study 2502165 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (all doses)
Number of subjects: 6
Study 2502165 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 mg 70 kg-1)
Number of subjects: 6
Study 2502165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 6
Study 29360455 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta plates
Number of subjects: 20
Study 29360455 — intervention group
Group type: COMPARATOR
Intervention: Conventional miniplates
Number of subjects: 20
Study 28041817 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial-multidisciplinary intervention
Number of subjects: 120
Study 28041817 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 26332408 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride mouthwash
Number of subjects: 91
Study 26332408 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with fixed appliances
Number of subjects: 91
Study 26332408 — intervention group
Group type: COMPARATOR
Intervention: Control (no fluoride mouthwash)
Number of subjects: 91
Study 24244325 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP-guided computerized decision support (CDS) algorithm
Number of subjects: 636
Study 24244325 — intervention group
Group type: COMPARATOR
Intervention: Non-compliance with CDS algorithm
Number of subjects: 636
Study 24244325 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP results
Number of subjects: 636
Study 24244325 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukopenia of any cell type
Number of subjects: 636
Study 20833235 — intervention group
Group type: EXPERIMENTAL
Intervention: Rooibos (fermented/traditional)
Number of subjects: 40
Study 18496307 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program
Number of subjects: 163
Study 18496307 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 163
Study 16192338 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural correlates of stimulus-action-reward association in the putamen
Number of subjects: 0
Study 16192338 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural correlates of reward-prediction error in the caudate nucleus and ventral striatum
Number of subjects: 0
Study 16192338 — intervention group
Group type: EXPERIMENTAL
Intervention: Task difficulty levels
Number of subjects: 0
Study 12953943 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC+ TO (clocortolone pivalate cream 0.1% + tacrolimus ointment 0.1%)
Number of subjects: 57
Study 11139095 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrythmic drugs
Number of subjects: 0
Study 11139095 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter‐defibrillator
Number of subjects: 0
Study 11139095 — intervention group
Group type: EXPERIMENTAL
Intervention: Other drugs
Number of subjects: 0
Study 11139095 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatment modalities
Number of subjects: 0
Study 9087151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 200 micrograms bid
Number of subjects: 55
Study 9087151 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray 200 micrograms bid
Number of subjects: 55
Study 9087151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 8436162 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid (aluminium hydroxide 800 mg and magnesium hydroxide 800 mg), tid, added to a stable regimen of theophylline SR bid for 4 days.
Number of subjects: 15
Study 8436162 — intervention group
Group type: COMPARATOR
Intervention: Placebo, tid, added to a stable regimen of theophylline SR bid for 4 days.
Number of subjects: 15
Study 3963039 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 ml/kg of 100-proof vodka in orange juice
Number of subjects: 78
Study 3963039 — intervention group
Group type: COMPARATOR
Intervention: Water in orange juice
Number of subjects: 78
Study 30636829 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 70
Study 30636829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 27186550 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU of Vitamin D daily (Group 1)
Number of subjects: 100
Study 27186550 — intervention group
Group type: EXPERIMENTAL
Intervention: 30,000 IU of Vitamin D monthly (Group 2)
Number of subjects: 100
Study 27186550 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU of Vitamin D daily (Group 3)
Number of subjects: 100
Study 27186550 — intervention group
Group type: EXPERIMENTAL
Intervention: 60,000 IU of Vitamin D monthly (Group 4)
Number of subjects: 100
Study 27186550 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2K (2000 IU daily and 60,000 IU monthly)
Number of subjects: 100
Study 27186550 — intervention group
Group type: COMPARATOR
Intervention: Group 1K (1000 IU daily and 30,000 IU monthly)
Number of subjects: 100
Study 24616307 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback of patient-reported outcomes (PROs) to oncologists and families (n = 51)
Number of subjects: 104
Study 24616307 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control group, n = 53)
Number of subjects: 104
Study 24175980 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week pedometer-driven walking program, brief intervention, and educational material
Number of subjects: 60
Study 24175980 — intervention group
Group type: COMPARATOR
Intervention: Educational material only
Number of subjects: 60
Study 21936939 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity strength training for the neck and shoulders three times a week for 20 weeks (n = 282)
Number of subjects: 537
Study 21936939 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving advice to stay physically active (n = 255)
Number of subjects: 537
Study 21936939 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity strength training (n = 282)
Number of subjects: 537
Study 18496373 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist-control ventilation
Number of subjects: 15
Study 18496373 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatically adjusted pressure support ventilation (aPSV)
Number of subjects: 15
Study 18496373 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically adjusted pressure support ventilation (cPSV)
Number of subjects: 15
Study 16634338 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor relearning programme
Number of subjects: 52
Study 16634338 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy programme
Number of subjects: 52
Study 14620030 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% KP
Number of subjects: 40
Study 14620030 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 14620030 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% KP
Number of subjects: 40
Study 14620030 — intervention group
Group type: EXPERIMENTAL
Intervention: No-KP
Number of subjects: 40
Study 10946866 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfeeding (130% TEE)
Number of subjects: 6
Study 10946866 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfeeding (70% TEE)
Number of subjects: 6
Study 10946866 — intervention group
Group type: COMPARATOR
Intervention: Eucaloric (100% TEE) washout (WASH)
Number of subjects: 6
Study 10946866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum intake after each treatment period
Number of subjects: 6
Study 8610913 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 1 mg/kg with atropine 10 micrograms/kg given when NMT of the AP was 1% or 10% of baseline
Number of subjects: 30
Study 8610913 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium given when NMT was 11% ± 1% SEM
Number of subjects: 30
Study 8610913 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous recovery
Number of subjects: 30
Study 1358852 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine 1.0%
Number of subjects: 30
Study 1358852 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.125%
Number of subjects: 30
Study 3571043 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin bolus iv injection (80 mg)
Number of subjects: 10
Study 3571043 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin infusion over 15 min (80 mg)
Number of subjects: 10
Study 29674270 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 136
Study 29674270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 27956676 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (FC) 6g
Number of subjects: 50
Study 25503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Lab-score group (Lab-score reported, blinded WBC count)
Number of subjects: 271
Study 25503770 — intervention group
Group type: COMPARATOR
Intervention: Control group (WBC, bands and C-reactive protein determined, blinded procalcitonin and Lab-score)
Number of subjects: 271
Study 25503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Lab-score recommendations (hypothetical scenario)
Number of subjects: 271
Study 25503770 — intervention group
Group type: EXPERIMENTAL
Intervention: Lab-score ≥3
Number of subjects: 271
Study 22704765 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal (TV) retrieval
Number of subjects: 66
Study 22704765 — intervention group
Group type: COMPARATOR
Intervention: Transumbilical (TU) retrieval
Number of subjects: 66
Study 22704765 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TV and TU)
Number of subjects: 66
Study 18506573 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week theory-based group intervention (for postpartum depression prevention)
Number of subjects: 594
Study 16901186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertaconazole nail patch (3.63 mg)
Number of subjects: 16
Study 16901186 — intervention group
Group type: COMPARATOR
Intervention: Control patch (no antifungal agent)
Number of subjects: 16
Study 12799627 — intervention group
Group type: COMPARATOR
Intervention: 5-FU/FA (5-FU 425 mg m(‐2) i.v. and FA 20 mg m(‐2) i.v. bolus days 1‐5 every 28 days for 6 months
Number of subjects: 716
Study 12799627 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI 5-FU (300 mg m(‐2) day for 12 weeks)
Number of subjects: 716
Study 12799627 — intervention group
Group type: COMPARATOR
Intervention: 5-FU/FA
Number of subjects: 716
Study 12799627 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI 5-FU
Number of subjects: 716
Study 9928753 — intervention group
Group type: EXPERIMENTAL
Intervention: felodipine-metoprolol 5/50 mg once daily
Number of subjects: 120
Study 9928753 — intervention group
Group type: COMPARATOR
Intervention: enalapril 10 mg once daily
Number of subjects: 120
Study 9928753 — intervention group
Group type: EXPERIMENTAL
Intervention: felodipine-metoprolol
Number of subjects: 120
Study 9928753 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 120
Study 9928753 — intervention group
Group type: EXPERIMENTAL
Intervention: felodipine-metoprolol and enalapril
Number of subjects: 120
Study 7495045 — intervention group
Group type: EXPERIMENTAL
Intervention: benazepril (10-20 mg once a day)
Number of subjects: 24
Study 2312804 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified iontophoretic method with an anticholinergic agent and aluminum chloride
Number of subjects: 0
Study 2312804 — intervention group
Group type: COMPARATOR
Intervention: Tap water iontophoresis
Number of subjects: 0
Study 648378 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (15 mg/day)
Number of subjects: 52
Study 648378 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (2 mg/kg daily)
Number of subjects: 52
Study 648378 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prednisone (10 mg/day) and azathioprine (2 mg/kg daily)
Number of subjects: 52
Study 648378 — intervention group
Group type: COMPARATOR
Intervention: Control group (HBs-antigen positive patients)
Number of subjects: 52
Study 31800872 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Ultrasonic Activation (PUA)
Number of subjects: 20
Study 31800872 — intervention group
Group type: COMPARATOR
Intervention: Conventional Needle Irrigation (CNI)
Number of subjects: 20
Study 31426835 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready2Change (R2C) intervention, n = 172, four to six sessions of structured telephone-delivered intervention, R2C self-help resource, guidelines for alcohol consumption and stress management pamphlets
Number of subjects: 344
Study 31426835 — intervention group
Group type: COMPARATOR
Intervention: Control condition, n = 172, four phone check-ins < 5 min, guidelines for alcohol consumption and stress management pamphlets
Number of subjects: 344
Study 28104375 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (prostate specific antigen testing)
Number of subjects: 80367
Study 28104375 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no prostate specific antigen testing)
Number of subjects: 80367
Study 28104375 — intervention group
Group type: COMPARATOR
Intervention: Control arm (prostate specific antigen testing)
Number of subjects: 80367
Study 28104375 — intervention group
Group type: COMPARATOR
Intervention: Screening arm vs Control arm
Number of subjects: 80367
Study 24742343 — intervention group
Group type: EXPERIMENTAL
Intervention: PursuingPleasure (PP) - online cognitive behavioral therapy program with mindfulness training and chat groups
Number of subjects: 57
Study 24742343 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 57
Study 24742343 — intervention group
Group type: EXPERIMENTAL
Intervention: PursuingPleasure (PP)
Number of subjects: 57
Study 23218813 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental parenteral nutrition (SPN)
Number of subjects: 305
Study 23218813 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition (EN)
Number of subjects: 305
Study 23218813 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN
Number of subjects: 305
Study 23218813 — intervention group
Group type: COMPARATOR
Intervention: EN
Number of subjects: 305
Study 22133241 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week progressive aquatic resistance training
Number of subjects: 50
Study 22133241 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 50
Study 19591723 — intervention group
Group type: EXPERIMENTAL
Intervention: LMX-4
Number of subjects: 43
Study 19591723 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hand cream)
Number of subjects: 43
Study 16490874 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast sodium (10 mg)
Number of subjects: 58
Study 16490874 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine hydrochloride (240 mg)
Number of subjects: 58
Study 15575054 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide or propafenone (self-administered)
Number of subjects: 210
Study 10927707 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-based telehealth care
Number of subjects: 302
Study 10927707 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth care plus peer support
Number of subjects: 302
Study 10927707 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302
Study 9264305 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.5%
Number of subjects: 0
Study 9264305 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 0
Study 9264305 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 0
Study 9264305 — intervention group
Group type: COMPARATOR
Intervention: Betatolol 0.25% suspension
Number of subjects: 0
Study 8377159 — intervention group
Group type: EXPERIMENTAL
Intervention: Home physiotherapy
Number of subjects: 0
Study 8377159 — intervention group
Group type: COMPARATOR
Intervention: Day hospital attendance
Number of subjects: 0
Study 3718378 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone, 25 mg PO QID for 48 h prior to and during exposure
Number of subjects: 9
Study 3718378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30400570 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (1 × 10^10 CFU per day)
Number of subjects: 81
Study 30400570 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (2.5 × 10^8 CFU per day)
Number of subjects: 81
Study 30400570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 27014884 — intervention group
Group type: EXPERIMENTAL
Intervention: Type D personality group
Number of subjects: 388
Study 27014884 — intervention group
Group type: COMPARATOR
Intervention: Social inhibition group
Number of subjects: 388
Study 27014884 — intervention group
Group type: COMPARATOR
Intervention: Group without negative affectivity and social inhibition
Number of subjects: 388
Study 27014884 — intervention group
Group type: COMPARATOR
Intervention: Negative affectivity group
Number of subjects: 388
Study 25042773 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported weights (n=191)
Number of subjects: 277
Study 25042773 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported weights
Number of subjects: 277
Study 22029714 — intervention group
Group type: EXPERIMENTAL
Intervention: B‐MICS
Number of subjects: 40
Study 22029714 — intervention group
Group type: COMPARATOR
Intervention: C‐MICS
Number of subjects: 40
Study 20858857 — intervention group
Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid-based therapy (in 155 patients with M3V)
Number of subjects: 155
Study 20858857 — intervention group
Group type: COMPARATOR
Intervention: All-trans retinoic acid-based therapy (in 748 patients with classical M3)
Number of subjects: 155
Study 18511608 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding Qa surveillance to monitoring (Flow)
Number of subjects: 159
Study 18511608 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 159
Study 16389183 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential BCG and electromotive mitomycin
Number of subjects: 212
Study 16389183 — intervention group
Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 212
Study 12375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 11
Study 12375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural orthotic
Number of subjects: 11
Study 12375295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 10355866 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment for 12 weeks
Number of subjects: 31
Study 10355866 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 31